Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide add-on to insulin and metformin in type 2 diabetes
2010-019956-32Phase 4Active
- Sponsor
- Steno Diabetes Center
- Start
- Jul 2010
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of liraglutide in type 2 diabetes mellitus (T2DM), sponsored by Steno Diabetes Center. Primary endpoint: Change in HbA1c from baseline to 12 weeks. Started Jul 2010; status: active.
02
Drugs
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2010-019956-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019956-32.